Sign In
Buy MLSS
$0.390
-0.0030 (-0.763%)
At Close: Jun 03, 2026
Milestone Scientific Delivers Stable Revenue and Reduces Operating Expenses by Over $500 Thousand in the Third Quarter of 2025
04:00pm, Thursday, 13'th Nov 2025
ROSELAND, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, to
Milestone Scientific Schedules Third Quarter 2025 Financial Results and Business Update Conference Call
02:15pm, Thursday, 13'th Nov 2025
ROSELAND, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, t
Milestone Scientific Highlights Operational Progress and Growth Initiatives Under New Leadership
07:50am, Tuesday, 14'th Oct 2025
Company outlines decisive initiatives to strengthen its dental and medical businesses, reduce operating expenses across the organization, and position Milestone Scientific for accelerated growth and i
Milestone Scientific Commits to Regaining NYSE American Compliance Following Notification
07:45am, Tuesday, 14'th Oct 2025
Notification has no immediate effect on the Company's listing or day-to-day operations Notification has no immediate effect on the Company's listing or day-to-day operations
Appointment strengthens Board expertise as Milestone Scientific drives commercial expansion and payer adoption of CompuFlo® in interventional pain management Appointment strengthens Board expertise a
Milestone Scientific Achieves 25% Increase in Revenue for the Second Quarter of 2025
04:15pm, Thursday, 14'th Aug 2025
Expands senior leadership team and board of directors to support next phase of growth Expands senior leadership team and board of directors to support next phase of growth
Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call
11:45am, Wednesday, 13'th Aug 2025
ROSELAND, N.J., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, to
Milestone Scientific Appoints Jason Papes as Senior Vice President, Global Head of Sales and Marketing
08:30am, Wednesday, 06'th Aug 2025
ROSELAND. N.J., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, to
Milestone Scientific Appoints Eric C. Hines as Chief Executive Officer
08:30am, Friday, 01'st Aug 2025
Seasoned executive with proven track record driving growth and building customer focused teams to lead Milestone's next phase of commercial execution Seasoned executive with proven track record drivin
Milestone Scientific Commences Sales of CompuFlo® Epidural System at The Painless Center in Tenafly, New Jersey
08:30am, Thursday, 17'th Jul 2025
ROSELAND, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, to
Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors
10:00am, Monday, 19'th May 2025
Brings Proven Commercial Leadership, Reimbursement Expertise, and Global Market Insight to Support Next Phase of Growth Across Medical and Dental Segments Brings Proven Commercial Leadership, Reimburs
Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2025
04:15pm, Thursday, 15'th May 2025
ROSELAND, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, tod
Milestone Scientific Expands CompuFlo® Epidural System Footprint with InfiniSurg, LLC in New Jersey
08:30am, Tuesday, 01'st Apr 2025
Dr. Roman Kosiborod, DO to Utilize CompuFlo® for Enhanced Precision in Pain Management Procedures Dr. Roman Kosiborod, DO to Utilize CompuFlo® for Enhanced Precision in Pain Management Procedures
Milestone Scientific Expands Adoption of CompuFlo® Epidural System with Commercial Rollout at Pain Doctors Medical LLC
10:00am, Tuesday, 04'th Feb 2025
Dr. Ilana Etelzon Integrates CompuFlo® Epidural System into Practice Following Positive Clinical Experience Dr. Ilana Etelzon Integrates CompuFlo® Epidural System into Practice Following Positive Cl
Reports Expanding Adoption of CompuFlo® Epidural System Following Previously Announced Medicare Price Assignment Reports Expanding Adoption of CompuFlo® Epidural System Following Previously Announce
